Your browser doesn't support javascript.
loading
Assessment of Imatinib in the treatment of chronic myeloid leukemia in Gabon: a cohort of 17 cases.
Gaudong Mbethe, G L; Mounguengui, D; Magne, C; Ondounda, M; Yboutsi, L; Ibaba, J; Moussavou Kombila, J B; Boguikouma, J B; Belembaogo, E; Nzenze, J R.
Affiliation
  • Gaudong Mbethe GL; Hôpital d'instruction des armées Omar Bongo Ondimba, Hôpital militaire de Libreville, BP 12038 Libreville, Gabon.
  • Mounguengui D; Hôpital d'instruction des armées Omar Bongo Ondimba, Hôpital militaire de Libreville, BP 12038 Libreville, Gabon.
  • Magne C; Hôpital d'instruction des armées Omar Bongo Ondimba, Hôpital militaire de Libreville, BP 12038 Libreville, Gabon.
  • Ondounda M; Hôpital d'instruction des armées Omar Bongo Ondimba, Hôpital militaire de Libreville, BP 12038 Libreville, Gabon.
  • Yboutsi L; Hôpital d'instruction des armées Omar Bongo Ondimba, Hôpital militaire de Libreville, BP 12038 Libreville, Gabon.
  • Ibaba J; Centre hospitalo-universitaire de Libreville, Gabon.
  • Moussavou Kombila JB; Centre hospitalo-universitaire de Libreville, Gabon.
  • Boguikouma JB; Centre hospitalo-universitaire de Libreville, Gabon.
  • Belembaogo E; Centre hospitalo-universitaire de Libreville, Gabon.
  • Nzenze JR; Hôpital d'instruction des armées Omar Bongo Ondimba, Hôpital militaire de Libreville, BP 12038 Libreville, Gabon.
Med Sante Trop ; 26(2): 184-8, 2016 May 01.
Article in En | MEDLINE | ID: mdl-27034089
The prognosis for chronic myeloid leukemia, the first hematologic malignancy for which successful targeted therapy has been developed, has changed markedly in the West. In developing countries, however, prognosis remains poor, mainly because of lack of access to treatment. The effort made by some nongovernmental organizations to distribute first-generation tyrosine kinase inhibitors free of charge has changed this situation in some regions, notably in sub-Saharan Africa and Gabon in particular. We report the results in a cohort of 17 patients.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Imatinib Mesylate / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Med Sante Trop Year: 2016 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Imatinib Mesylate / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Med Sante Trop Year: 2016 Document type: Article